Current Pharmacological Management of Hypotensive Syndromes in the Elderly

Drugs and Aging

Volumn 32, Issue 5, 2015, Pages 337-348

  Alagiakrishnan, Kannayiram ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR; ANTIHYPERTENSIVE AGENT; ATOMOXETINE; CAFFEINE; DESMOPRESSIN; DIHYDROERGOTAMINE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; DOMPERIDONE; DROXIDOPA; FLUDROCORTISONE; GLYCERYL TRINITRATE; GUAR GUM; METOCLOPRAMIDE; METOPROLOL; MIDODRINE; OCTREOTIDE; PYRIDOSTIGMINE; RECOMBINANT ERYTHROPOIETIN; SODIUM CHLORIDE; YOHIMBINE;

CARDIOVASCULAR DISEASE; CAROTID SINUS SYNDROME; CHILL; CORTICOSTEROID THERAPY; DEPRESSION; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; FAINTNESS; HEAD MOVEMENT; HEADACHE; HEART FAILURE; HUMAN; HYPERSALIVATION; HYPERTENSION; HYPOKALEMIA; HYPOTENSION; MEDICATION THERAPY MANAGEMENT; MORBIDITY; MORTALITY; MUSCLE CRAMP; NAUSEA; ORTHOSTATIC HYPOTENSION; PARESTHESIA; POSTPRANDIAL HYPOTENSION; PRIORITY JOURNAL; REFLEX; REVIEW; SCALP PRURITUS; SIDE EFFECT; SUPINE HYPERTENSION; URINE RETENTION; AGED; BLOOD PRESSURE; DRUG EFFECTS; PATHOPHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HUMANS; HYPOTENSION;

EID: 84930045231     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.1007/s40266-015-0263-z     Document Type: Review

References (136)

1. Low PA. Prevalence of orthostatic hypotension. Clin Auton Res. 2008;18(suppl 1):8–13.
2. Vloet LC, Pel-little RE, Jansen PA, et al. High prevalence of postprandial and orthostatic hypotension among geriatric patients admitted to Dutch hospitals. J Gerontol A Biol Sci Med Sci. 2005;60(10):127–1277.
3. Kenny RA, Richardson DA. Carotid sinus syndrome and falls in older adults. Am J Geriatr Cardiol. 2001;10(2):97–9.
4. Lagro J, Meet-vanden Abeelen A, de Jong DL, Schalk BW, Olde Rikkert MG, Classen JA. Geriatric hypotensive syndromes are not explained by cardiovascular autonomic dysfunction alone. J Gerontol A Biol Sci Med Sci. 2013;68(5):581–9.
5. Le Couteur DG, Fisher AA, Davis MW, McLean AJ. Post prandial systolic blood pressure responses of older people in residential care association and risk of falling. Gerontology. 2003;49:260–4.
6. Kenny RA, Richardson DA. Carotid sinus syndrome and falls in older adults. Am J Geriatr Cardiol. 2001;10:97–9.
7. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Neurology. 1996;46(5):1470.
8. Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neutrally mediated syncope and the postural tachycardia syndrome. Auton Neurosc. 2011;161:46–8.
9. Rutan GH, Hermanson B, Bild DE, et al. Orthostatic hypotension in older adults. The Cardiovascular Health Study. CHS Colloborative Research Group. Hypertension. 1992;19:508–19.
10. Shibao C, Grijalva CG, Raj SR, et al. Orthostatic hypotension related hospitalizations in the United States. Am J Med. 2007;120:975–80.
11. Feldstein C, Weder AB. Orthostatic hypotension: a common, serious and under recognized problem in hospitalized patients. J Am Soc Hypertens. 2012;6:27–39.
12. Ooi WL, Barett S, Hossain M, Reiley-Gagnon M, Lipsitz LA. Patterns of orthostatic blood pressure change and their clinical correlates in a frail, elderly population. JAMA. 1997;277(16):1299–304.
13. Sclater A, Alagiakrishnan K. Orthostatic hypotension. A primary care primer for assessment and treatment. Geriatrics. 2004;59(9):22–7.
14. Masaki KH, Schatz IJ, Burchfield CM, et al. Orthostatic hypotension predicts mortality in elderly men: the Honolulu Heart Program. Circulation. 1998;98:2290–5.
15. Weiss A, Beloosesky Y, Kornowski R, et al. Influence of orthostatic hypotension on mortality among patients discharged from an acute geriatric ward. J Gen Intern Medicine. 2006;21:602–6.
16. Xin W, Lin Z, Mi S. Orthostatic hypotension and mortality risk: a meta-analysis of cohort studies. Heart. 2014;100:406–13.
17. Verwoert GC, Mattace-Raso FU, Hofman A, Heeringa J, Stricker BH, Breteler MM, et al. Orthostatic hypotension and risk of cardiovascular disease in elderly people: the Rotterdam Study. J Am Geriatr Soc. 2008;56:1816–20.
18. Luukinen H, Koski K, Laippala P, Airaksinen KE. Orthostatic hypotension and the risk of myocardial infarction in the home-dwelling elderly. J Intern Med. 2004;255:486–93.
19. Kario K, Eguchi K, Hoshide S, Hoshide Y, Umeda Y, Mitsuhashi T, Shimada K. U-curve relationship between orthostatic blood pressure change and silent cerebrovascular disease in elderly hypertensives: orthostatic hypertension as a new cardiovascular risk factor. J Am Coll Cardiol. 2002;40:133–41.
20. Hossain M, Ooi WL, Lipsitz LA. Intra-individual postural blood pressure variability and stroke in elderly nursing home residents. J Clin Epidemiol. 2001;54:488–94.
21. Alagiakrishnan K, Patel K, Desai RV, et al. Orthostatic hypotension and incident heart failure. J.Gerontol A Biol Sci Med Sci. 2014;69A(2):223–30.
22. Sarasin FP, Louis-Simonet M, Carballo D, et al. Prevalence of OH among patients presenting with syncope in the ED. Am J Emerg Med. 2002;20:497–501.
23. Van Hatteran KJ, Kleefstra N, Blanker MH, et al. Orthostatic hypotension, diabetes and falling in older adults: a cross-sectional study. Br J Gen. Practice. 2012. doi:10.3399/bjgp12x656838.
24. Rutan GH, Hermanson B, Bild DE, et al. Orthostatic hypotension in older adults. The Cardiovascular Health Study, CHS Collobarative Research Group. Hypertension. 1992;19:508–19.
25. Casiglia E, Tikhonoff V, Caffi S, et al. Orthostatic hypotension does not increase cardiovascular risk in the elderly at a population level. Am J Hypertens. 2014;27(1):81–8.
26. Sonnesyn H, Nilsen DW, Rongve A, Nore S, Ballard C, Tysnes OB, Aarsland D. High prevalence of orthostatic hypotension in mild dementia. Dement Geriatr Cogn Disord. 2009;28:307–13.
27. Andersson M, Hansson O, Minthon L, Ballard CG, Londos E. The period of hypotension following orthostatic challenge is prolonged in dementia with lewy bodies. Int J Geriatr Psychiatry. 2008;23:192–8.
28. Yap PL, Niti M, Yap KB, et al. Orthostatic hypotension, hypotension and cognitive status: early comorbid markers of primary dementia? Dement Geriatr Cogn Disord. 2008;26:239–46.
29. Frewen J, Savya GM, Boyle G, et al. Cognitive performance in orthostatic hypotension. Findings from a nationally representative sample. J Am Geriatr Soc. 2014;62(1):117–22.
30. Mehrabian S, Duron E, Labouree F, et al. Relationship between orthostatic hypotension and cognitive impairment in the elderly. J Neurol Sci. 2010;299:45–8.
31. Elmstahl S, Rosen I. Postural hypotension and EEG variables predict cognitive decline: results from a 5-year follow-up of healthy elderly women. Dement Geriatr Cogn Disord. 1997;8:180–7.
32. Matsubayashi K, Okumiya K, Wada T, et al. Postural dysregulation in systolic blood pressure is associated with worsened scoring on neurobehavioral function tests and leukoaraiosis in the older elderly living in a community. Stroke. 1997;28:2169–73.
33. Bonuccelli U, Lucetti C, Del DP, Ceravolo R, Gambaccini G, Bernardini S, Rossi G, Piaggesi A. Orthostatic hypotension in de novo Parkinson’s disease. Arch Neurol. 2003;60:1400–4.
34. Goldstein DS, Eldadah BA, Holmes C, Pechnik S, Moak J, Saleem A, Sharabi Y. Neurocirculatory abnormalities in Parkinson disease with orthostatic hypotension: independence from levodopa treatment. Hypertension. 2005;46:1333–9.
35. Mehagnoul-Schipper DJ, Boerman RH, Hoefnagels WH, Jansen RW. Effect of levodopa on orthostatic and postprandial hypotension in elderly Parkinsonian patients. J Gerontol A Biol Sci Med Sci. 2001;56:M749–55.
36. Kujawa K, Leurgans S, Raman R, Blasucci L, Goetz CG. Acute orthostatic hypotension when starting dopamine agonists in Parkinson’s disease. Arch Neurol. 2000;57:1461–3.
37. Dooley M Markham A. Pramipexole: a review of its use in the management of early and advanced Parkinson’s disease. Drugs Aging. 1998;12:495–514.
38. Johns DW, Ayers CR, Carey RM. The dopamine agonist bromocriptine induces hypotension by venous and arteriolar dilation. J Cardiovasc Pharmacol. 1984;6:582–7.
39. Allcock LM, Kenny RA, Mosimann UP, Tordoff S, Wesnes KA, Hildreth AJ, Burn DJ. Orthostatic hypotension in Parkinson’sdisease: association with cognitive decline? Int J Geriatr Psychiatry. 2006;21:778–83.
40. Pilleri M, Facchini S, Gasparoli E, Biundo R, Bernardi L, Marchetti M, Formento P, Antonini A. Cognitive and MRI correlates of orthostatic hypotension in Parkinson’s disease. J Neurol. 2013;260:253–9.
41. Low PA, Opter-Gehrking H, Mcphee BR, et al. Prospective evaluation of clinical characteristics of orthostatic hypotension. Mayo Clin Proc. 1995;70(7):617–22.
42. Ooi WL, Hossain M, Lipsitz LA. The association between orthostatic hypotension and recurrent falls in nursing home residents. Am J Med. 2000;108:106–11.
43. Gangavati A, Hajjar I, Quach L, Jones RN, Kiely DK, et al. Hypertension, orthostatic hypotension, and the risk of falls in a community-dwelling elderly population: the maintenance of balance, independent living, intellect, and zest in the elderly of Boston study. J Am Geriatr Soc. 2011;59:383–9.
44. van Hateren KJ, Kleefstra N, Blanker MH, Ubink-Veltmaat LJ, Groenier KH, et al. Orthostatic hypotension, diabetes, and falling in older patients: a cross-sectional study. Br J Gen Pract. 2012;62:e696–702.
45. Pasma JH, Bijlsma AY, Klip JM, Stijintjes M, Blauw GJ, Muller M, et al. Blood pressure associated with standing balance in elderly outpatients. PLoS One. 2014;9(9):e106808.
46. Arnold AC, Shibao C. Current concepts in orthostatic hypotension management. Curr Hypertens Rep. 2013;15:304–12.
47. Campbell IW, Ewing DJ, Clarke BF. 9-Alpha–fludrocortisone in the treatment of postural hypotension in diabetic autonomic neuropathy. Diabetes. 1975;24:381–4.
48. Kaufmann H, Brannan T, Krakoff L, Yahr MD, Mandeli J. Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine). Neurology. 1988;38:951–6.
49. Schoffer KL, Henderson RD, O’Maley K, O’Sullivan ID. Non pharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson’s disease. Mov Disorder. 2007;22:1543–9.
50. Hussain RM, McIntosh SJ, Lawson J, Kenny RA. Fludrocortisone in the treatment of hypotensive disorders in the elderly. Heart. 1996;76(6):507–9.
51. Chobanian AV, Volicer L, Tifft CP, et al. Mineralocorticoid-induced hypertension in patients with orthostatic hypotension. N Engl J Med. 1979;301:68.
52. McClellan KJ, Wiseman LR, Wilde MI. Midodrine. A review of its therapeutic use in the management of orthostatic hypotension. Drugs Aging. 1998;12(1):76–86.
53. Low PA, Gilden JL, Freeman R, Sheng RN, McElligot MA. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multi-centre study. Midodrine Study Group. JAMA. 1997;277(13):1046–51.
54. Parsalk AK, Singh B, Altayar O, Mascarenhas SS, Singh SK, Erwin PJ, Murrad MH. Midodrine for orthostatic hypotension: a systematic review and meta-analysis of clinical trials. J Gen Intern Med. 2013;28(11):1496–503.
55. Hoeldtke RD, Horvath GG, Bryner KD, Hobbs GR. Treatment of orthostatic hypotension with midodrine and octreotide. J Clin Endocrinol Metab. 1998;83:339–43.
56. Jankovie J, Gilden JL, Hiner BC, et al. Neurogenic orthostatic hypotension: a double-blind. placebo-controlled study with midodrine. Am J Med. 1993;95:38–48.
57. Rao SV, Stamler JS. Erythropoietin, anemia, and orthostatic hypotension: the evidence mounts. Clin Auton Res. 2002;12:141–3.
58. Perera R, Isola L, Kaufmann H. Effect of recombinant erythropoietin on anemia and orthostatic hypotension in primary autonomic failure. Clin Auton Res. 1995;5:211.
59. Hoeldtke RD, Streeten DH. Treatment of orthostatic hypotension with erythropoietin. N Engl J Med. 1993;329:611–5.
60. Biaggioni I, Freeman R, Mathias CJ, et al. Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa. Hypertension. 2015;65(1):101–7.
61. Akizawa T, Koshikawa S, Iida N, et al. Clinical effects of l-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in hemodialysis patients. Nephron. 2002;90:384–90.
62. Lida N, Koshikawa S, Akizawa T, et al. Effects of l-threo 3,4-dihydroxyphenylserine on orthostatic hypotension in hemodialysis patients. Am J Nephrol. 2002;22:338–46.
63. Mathias CJ, Senard JM, Braun S, et al. l-threo-dihydroxyphenylserine (l-threo-DOPS), droxidopa in the management of neurogenic orthostatic hypotension: a multi-national, multi-centre, dose-ranging study in multiple system atrophy and pure autonomic failure. Clin Auton Res. 2001;11:235–42.
64. Isaacson SH, Skettini J. Neurogenic orthostatic hypotension in Parkinson’s disease: evaluation, management and emerging role of droxidopa. Vasc Health Risk Manag. 2014;10:169–76.
65. Isaacson S, Hauser RA, Szakacs CBN, Cioffi CC. Impact of droxidopa treatment in patients with Parkinson’s disease and symptomatic neurogenic orthostatic hypotension (study 306). Mov Disorder. 2013;28(Suppl 1):468.
66. Kaufmann H, Freeman R, Biaggioni I, et al. Droxidopa for neurogenic orthostatic hypotension. A randomized, placebo-controlled, phase 3 trial. Neurology. 2014;83(4):328–35.
67. Hauser RA, Hewitt LA, Isaacson S. Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson’s disease. J Parkinsons Dis. 2014;4(1):57–65.
68. Singer W, Sandroni P, Opfer-Gehrking TL, et al. Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol. 2006;63(4):513–8.
69. Shibao C, Okamoto LE, Gamboa A, et al. Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure. Hypertension. 2010;56:847–51.
70. Gales BJ, Gales MA. Pyridostigmine in the treatment of orthostatic intolerance. Ann Pharmacother. 2007;41(2):314–8.
71. Bordet R, Benhadjali J, Libersa C, Destee A. Octreotide in the management of orthostatic hypotension in multiple system atrophy; pilot trial of chronic administration. Clin Neuropharmacol. 1994;17:380–3.
72. Bordet R, Benhadjali J, Destee A, belabbas A, Libersa C. Octreotide effects on orthostatic hypotension in patients with multiple system atrophy: a controlled study of acute administration. Clin Neuropharmacol. 1995;18:83–9.
73. Onrol J, Goldberg MR, Biaggioni I, et al. Oral yohimbine in human autonomic failure. Neurology. 1987;37:215.
74. Jordan J, Shannon JR, Biaggioni I, Norman R, Black BK, Robertson D. Contrasting actions of pressor agents in severe autonomic failure. Am J Med. 1998;105:116–24.
75. Robertson D, Frolich JC, Carr RK, et al. Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med. 1978;298:181–6.
76. Okamoto LE, Shibao C, Gamboa A, et al. Synergistic effect of norepinephrine transporter blockade and alpha-2 antagonism on blood pressure in autonomic failure. Hypertension. 2012;59:650–6.
77. Ramirez CE, Okamoto LE, Arnold AC, et al. Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure. Hypertension. 2014 (in press).
78. Conte JJ, Fournie GJ, Maurette MH. Dihydroergotamine: an effective treatment for postural hypotension due to antihypertensive drugs (ganglion-blocking agents excepted). Cardiology. 1976;61(Suppl. 1):342–9.
79. Lubke KO. A controlled study with Dihydergot on patients with orthostatic dysregulation. Cardiology. 1976;61(Suppl. 1):333–41.
80. Victor RG, Talman WT. Comparative effects of clonidine and dihydroergotamine on venomotor tone and orthostatic tolerance in patients with severe hypoadrenergic orthostatic hypotension. Am J Med. 2002;112:361–8.
81. Lopes de Farina SR, Zanella MT, Andriolo A, et al. Peripheral dopaminergic blockade for the treatment of diabetic orthostatic hypotension. Clin Pharmacol Ther. 1988;44:670.
82. Mathias CJ, Fosbracy P, da Costa DF, Thornley A, Bannister B. The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure. Br Med J (Clin Res Ed). 1986;293:353–4.
83. Low PA, Singer W. Management of neurogenic orthostatic hypotension: an update. Lancet Neurol. 2008;7(5):451–8.
84. Logan IC, Witham MD. Efficacy of treatments for orthostatic hypotension: a systematic review. Age Ageing. 2012;41:587–94.
85. Alagiakrishnan K. Postural and postprandial hypotension: approach to management. Geriatr Aging. 2007;10(5):298–304.
86. Lipsitz LA, Nyquist RP Jr, Wei JY, et al. Postprandial reduction in blood pressure in the elderly. N Engl J Med. 1983;309:81–3.
87. Jansen RW, Lipsitz LA. Postprandial hypotension: epidemiology, pathophysiology and Clinical management. Ann Intern Med. 1995;122:286–95.
88. Luciano GL, Brennan MJ, Rothberg MB. Postprandial hypotension. Am J Med. 2010;123:281e1–6.
89. Vloet LC, Pei-Little RE, Jansen PA, et al. High prevalence of postprandial and orthostatic hypotension among geriatric patients admitted to Dutch hospitals. J Gerontolgical A Biol Sci Med Sci. 2005;60:1271–7.
90. Aronow WS, Ahn C. Postprandial hypotension in 499 elderly persons in a long-term healthcare facility. J Am Geriatr Soc. 1994;42:930–2.
91. Vaitkeviclus PV, Esserwein DM, Maynard AK, et al. Frequency and importance of postprandial blood pressure reduction in elderly nursing home patients. Ann Intern Med. 1991;115:865–70.
92. Fisher AA, Davis MW, Srikusalanukul W, et al. Postprandial hypotension predicts all-cause mortality in older, low-level care residents. J Am Gerontol Soc. 2005;53:1313–20.
93. Jansen RW, Connelly CM, Kelly-Gagnon MM, et al. Postprandial hypotension in elderly patients with unexplained syncope. Arch Intern Med. 1995;155:945–52.
94. Pulsieux F, Bulckaen, Fauchais AL, et al. Ambulatory blood pressure monitoring and postprandial hypotension in elderly persons with falls or syncopes. J Gerontol A Biol Sci Med Sci. (2000;55A:M535–40).
95. Aronow WS, Ahn C. Association of postprandial hypotension with incidence of falls, syncope, coronary events, stroke, and total mortality at 29-months follow-up in 499 older nursing home residents. J Am Geriatr Soc. 1997;45:1051–3.
96. Tabara Y, Okada Y, Detani E, Nagai T, Igase M, Kido T, et al. Postprandial hypotension as a risk marker for asymptomatic lacunar infarction. J Hypertens. 2014;32:1084–90.
97. Rakic V, Beilin IJ, Burke V. Effect of coffee and tea drinking on postprandial hypotension in older men and women. Clin Exp Pharmacol Physiol. 1996;23:559–63.
98. Heseltine D, Dakkak M, Woodhouse K, et al. The effect of caffeine on post prandial hypotension in the elderly. J Am Geriatr Soc. 1991;39:160–4.
99. Heseltine D, el-Jabri M, Ahmed F, Knox J. The effect of caffeine on post prandial blood pressure in the frail elderly. Postgrad Med J. 1991;67:543–7.
100. Lipsitz LA, Jansen RW, Connelly CM, et al. Haemodynamic and neurohumoral effects of caffeine in elderly patients with symptomatic postprandial hypotension: a double-blind, randomized, placebo-controlled study. Clin Sci (Lond).1994;87:259–67.
101. Gentilcore D, Bryant B, Wishart JM, et al. Acarbose attenuates the hypotensive response to sucrose and slows gastric emptying in the elderly. Am J Med. 2005;118:1289.
102. Maruta T, Komai K, Takamori M, Yamada M. Voglibose inhibits postprandial hypotension in neurological disorders and elderly people. Neurology. 2006;66:1432–4.
103. Shibao C, Gamboa A, Diedrich A, et al. Acarbose, an alpha-glucosidase inhibitor attenuates postprandial hypotension in autonomic failure. Hypertension. 2007;50:54–61.
104. Jian ZJ, Zhou BV. Efficacy and safety of acarbose in the treatment of elderly patients with postprandial hypotension. Chin Med J (Engl). 2008;121:2054–9.
105. Fukushima T, Asahina M, Fujinuma Y, et al. Role of intestinal peptides and the autonomic nervous system in post prandial hypotension in patients with multiple system atrophy. J Neurol. 2012;260:475–81.
106. Jian ZJ, Zhou BV. Efficacy and safety of acarbose in the treatment of elderly patients with postprandial hypotension. Chin Med J (Engl). 2008;121:2054–9.
107. Jansen RWMM, Peeters TL, Lenders JWM, et al. Somatostatin analog octreotide (SMS 201-995) prevents the decrease in blood pressure after oral glucose loading in the elderly. J Clin Endocrinol Metab. 1989;68:752–6.
108. Jansen RWMM, Lenders JWM, Peeters TL, et al. SMS 201-995 prevents postprandial blood pressure reduction in normotensive and hypertensive elderly subjects. J Hypertens. 1988;S6:S669–72.
109. Jones KL, Macintosh C, Su YC, Wells F, Chapman IM, Tonkin A, Horowitz M. Guar gum reduces post prandial hypotension in older people. J Am Geriatr Soc. 2001;49(2):162–7.
110. Russo A, Stevens JE, Wilson T, Wells F, Tonkin A, Horowitz M, Jones KL. Guar attenuates fall in postprandial blood pressure and slows gastric emptying of oral glucose in type 2 diabetes. Dig Dis Sci. 2003;48(7):1221–9.
111. Freeman B, Young J, Landsberg L, Lipsitz L. The treatment of postprandial hypotension in autonomic failure with DL-threo dihydroxy phenyl serine. Neurology. 1996;47:1414–20.
112. Yonenaga A, Ota H, Honda M, et al. Marked improvement of elderly postprandial hypotension by dipeptidyl peptidase IV inhibitor. Geriatr Gerontol Int. 2013;13(1):227–9.
113. Brignole M, Alboni P, Benditt DG, et al. Guidelines on management (diagnosis and treatment) of syncope-update 2004: executive summary. Eur Heart J. 2004;25:2054–72.
114. Kenny RA, Traynor G. Carotid sinus syndrome—clinical characteristics in elderly patients. Age Ageing. 1991;20:449–54.
115. McIntosh SJ, Lawson J, Kenny RA. Clinical characteristics of vasodepressor, cardio inhibitory and mixed carotid sinus syndrome in the elderly. Am J Med. 1993;95:203–8.
116. Schoon Y, Olde Rikkert MGM, Rongen S, Lagro J, Schalk B, Classen JAHR. Head turning induced hypotension in elderly people. Plos One. 2013;8(8):e72837.
117. Tan MP, Kenny RA, Chadwick TJ, et al. Carotid sinus hypersensitivity disease state or clinical sign of ageing? Insights from a controlled study of autonomic function in symptomatic and asymptomatic subjects. Eurospace. 2010;12:1630–6.
118. Hampton JL, Brayne C, Bradley M, Kenny RA. Mortality in carotid sinus hypersensitivity: a cohort study. BMJ Open. 2011;1:e000020.
119. McIntosh S, Da Costa D, Kenny RA. Outcome of an integrated approach to the investigation of dizziness, falls and syncope in elderly patients referred to a syncope clinic. Age Ageing. 1993;22:53–8.
120. Kenny RA, Traynor G. Carotid sinus syndrome—clinical characteristics in elderly patients. Age and Ageing. 1991;20:449–54.
121. Classen JA, Jansen RW. Carotid sinus syndrome: looking sideways is sufficient cause for syncope. J Am Geriatr Soc. 2006;54:188–9.
122. Schoon Y, Marcel GM, Rikkert O, Rongen S, Lagro J, Schalk B, Classen JA. Head turning-induced hypotension in elderly people. PLoS One. 2013;8(8):e72837.
123. Kerr SR, Pearce MS, Brayne C, Davis RJ, Kenny RA. Carotid sinus hypersensitivity in asymptomatic older persons. Arch Intern Med. 2006;166:515–20.
124. DaCosta D, McIntosh S, Kenny RA. Benefits of fludrocortisone in the symptomatic vasodepressor carotid sinus syndrome. Br Heart J. 1993;69:308–10.
125. Moore A, Watts M, Sheehy T, et al. Treatment of vasodepressor carotid sinus syndrome with midodrine: a randomized controlled pilot study. J Am Geriatr Soc. 2005;53:114–8.
126. Sheldon R, Morillo CA, Krahn A. Management of vasovagal syncope: 2004. Expert Rev Cardiovasc Ther. 2004;2(6):915–23.
127. Duncan GW, Tan MP, Newton JL, et al. Vasovagal syncope in the older persons: differences in presentation between older and younger patients. Age and Ageing. 2010;39:465–70.
128. Soteriades ES, Evans JC, Larson MG, et al. Incidence and prognosis of syncope. N Engl J Med. 2002;347(12):878–85.
129. Sheldon R, Connoly S, Rose S, et al. POST Investigators, Prevention of Syncope Trial (POST): a randomized, placebo-controlled study in the prevention of vasovagal syncope. Circulation. 2006;113:1164–70.
130. Sheldon R, Morillo C, Klingenheben T, et al. Age-dependent effect of beta-blockers in preventing vasovagal syncope. Circ Arrhythm Electrophysiol. 2012;5:920–6.
131. Shannon J, Jordan J, Costa F, et al. The hypertension of autonomic failure and its treatment. Hypertension. 1997;1062:30.
132. Jordan J, Shannon JR, Pohar B, et al. Contrasting effects of vasodilators on blood pressure and sodium balance in the treatment of hypertension of autonomic failure. J Am Soc Nephrol. 1999;10:36.
133. Nwazue VC, Raj SR. Confounders of vasovagal syncope: orthostatic hypotension. Cardiol Clin. 2013;31:89.
134. Fan CW, Walsh C, Cunnigham CJ. The effect of sleeping with the head of the bed elevated six inches on elderly patients with orthostatic hypotension: an open randomized controlled trial. Age Ageing. 2011;40:187.
135. Bannister R, Ardill L, Fenten P. An assessment of various methods of treatment of idiopathic orthostatic hypotension. Quart J med. 1969;38:377–95.
136. Morley JE. Hypertension—is it overtreated in the elderly. JAMDA. 2010;11:147–152.